New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

IBBQvsPBEETF Comparison

ETF 1
IBBQ

Invesco Nasdaq Biotechnology ETF

This fund is part of
US Health Care
+1.21%
VS
ETF 2
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
+2.4%

Invesco Nasdaq Biotechnology ETF (IBBQ) belongs to the US Health Care segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. IBBQ's top 2 sector exposures are Healthcare and Non-Energy Materials. In contrast, PBE's top sector exposures are Healthcare. IBBQ is less expensive with a Total Expense Ratio (TER) of 0.19%, versus 0.59% for PBE. IBBQ is up 22.79% year-to-date (YTD) with +$19M in YTD flows. PBE performs worse with 15.35% YTD performance, and +$114M in YTD flows. Run a side-by-side ETF comparison of IBBQ and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IBBQ vs PBE performance and flow charts

Performance

0.02.04.06.08.0%Aug 14Aug 21Aug 28Sep 4Sep 14

Cumulative Flows

0 M20 M40 M60 M80 MAug 14Aug 21Aug 28Sep 4Sep 14

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/14/2026
1M3MYTD1Y3Y5Y
Perf.
IBBQ
PBE
+2.85%-0.03%
+16.89%+11.40%
+22.79%+15.35%
+48.06%+37.16%
+74.15%+58.59%
+36.86%+26.94%
Flows
IBBQ
PBE
+$13M+$27M
+$18M+$117M
+$19M+$114M
+$38M+$113M
+$54M+$62M
+$28M+$64M
Volatility and drawdown
3M1Y3Y5Y
Volatility
IBBQ
PBE
+23.84%+19.39%
+21.54%+19.15%
+20.91%+20.49%
+22.08%+22.56%
Max drawdown
IBBQ
PBE
-6.48%-5.97%
-8.38%-11.70%
-23.78%-22.21%
-37.23%-33.32%
Max drawdown duration
IBBQ
PBE
26d11d
48d166d
375d324d
1485d1509d
Trading data

Create an account to view trading data

Join for free
IBBQ
PBE
Last sale
9/15/2026 at 1:30 PM
$34.19
$92.94
Previous close
09/14/2026
$34.82
$93.64
Consolidated volume
09/14/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IBBQ
PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/15/2026 at 1:30 PM
Live
Closed
IBBQ
PBE
Last price
$34.19
$92.94
1D performance
-1.81%
-0.75%
AuM$96.64 M$408.56 M
E/R0.19%0.59%
Characteristics
IBBQ
PBE
Management strategyPassivePassive
ProviderInvescoInvesco
BenchmarkNASDAQ Biotechnology IndexDynamic Biotech & Genome Intellidex Index
N° of holdings24930
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 9, 2021June 23, 2005
ESGNoNo
Advertisement
Exposure

Countries

IBBQ
USA
88.05%
Other
11.95%
PBE
USA
97.13%
Other
2.87%

Sectors

IBBQ
Healthcare
99.91%
Other
0.09%
PBE
Healthcare
100%
Other
0%
Advertisement

Diversification

IBBQ

Total weight of top 15 holdings out of 15

50.47%
PBE

Total weight of top 15 holdings out of 15

61.32%

Top 15 holdings

Data as of July 31, 2026
IBBQ
Amgen, Inc.
8.55%
Vertex Pharmaceuticals, Inc.
8.03%
Gilead Sciences, Inc.
7.34%
Regeneron Pharmaceuticals, Inc.
5.08%
Revolution Medicines, Inc.
2.73%
Alnylam Pharmaceuticals, Inc.
2.71%
Biogen, Inc.
2.19%
Illumina, Inc.
2.09%
Royalty Pharma Plc
1.86%
Incyte Corp.
1.80%
argenx SE
1.73%
Roivant Sciences Ltd.
1.68%
Insmed, Inc.
1.58%
United Therapeutics Corp.
1.58%
Moderna, Inc.
1.53%
PBE
Amgen, Inc.
5.16%
Vertex Pharmaceuticals, Inc.
4.96%
Royalty Pharma Plc
4.91%
Regeneron Pharmaceuticals, Inc.
4.90%
Biogen, Inc.
4.85%
Gilead Sciences, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.34%
United Therapeutics Corp.
4.06%
CareDx, Inc.
4.01%
Bio-Techne Corp.
3.66%
Illumina, Inc.
3.27%
Vericel Corp.
3.25%
Protagonist Therapeutics, Inc.
3.24%
Incyte Corp.
3.19%
Veracyte, Inc.
3.07%
Frequently asked questions about IBBQ and PBE

How have the IBBQ and PBE ETFs performed in 2026?

As of September 14, 2026, IBBQ is up 22.79% year-to-date (YTD), while PBE has returned 15.35%. That puts IBBQ better performer ahead so far this year.

Which ETF is attracting more investor money: IBBQ or PBE?

Year-to-date, the IBBQ ETF saw +$19M in flows, compared to +$114M for PBE.

Which ETF is more volatile: IBBQ or PBE?

Over the past year, IBBQ had a volatility of 21.54%, while PBE experienced 19.15%.

Which ETF is bigger: IBBQ or PBE?

As of September 14, 2026, IBBQ holds $96.64 M in assets under management (AUM), while PBE manages $408.56 M.

What sectors do the IBBQ and PBE ETFs invest in?

IBBQ leans toward sectors like Healthcare. Meanwhile, PBE focuses on Healthcare.

What are the top holdings of the IBBQ ETF and PBE ETF?

IBBQ top holdings include Amgen, Inc., Vertex Pharmaceuticals, Inc. and Gilead Sciences, Inc.. PBE holds in its top three: Amgen, Inc., Vertex Pharmaceuticals, Inc. and Royalty Pharma Plc.

Which ETF is more diversified: IBBQ or PBE?

IBBQ holds 249 securities with 50.47% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 61.32%.

Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder